Sedative effects on physiological and psychological measures in anxious patients.
D000654:Amobarbital / Q000627:therapeutic use*; D014151:Anti-Anxiety Agents / Q000627:therapeutic use*; D001007:Anxiety; D001307:Auditory Perception; D002707:Chlordiazepoxide / Q000627:therapeutic use; D002908:Chronic Disease; D002986:Clinical Trials as Topic; D003975:Diazepam / Q000627:therapeutic use; D004569:Electroencephalography; D005071:Evoked Potentials; D005712:Galvanic Skin Response / Q000187:drug effects; D006801:Humans; D008433:Mathematics; D008472:Medazepam / Q000627:therapeutic use; D009048:Motor Skills / Q000187:drug effects; D010919:Placebos; D011674:Pulse / Q000187:drug effects; D011930:Reaction Time / Q000187:drug effects; D012025:Reflex, Pupillary / Q000187:drug effects; D013997:Time Factors
D014151:Anti-Anxiety Agents; D010919:Placebos; D002707:Chlordiazepoxide; D000654:Amobarbital; D008472:Medazepam; D003975:Diazepam